Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 22.19
-0.43 (-1.90%)
May 12, 2026, 3:00 PM CST
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 8.95 billion as of May 12, 2026. Its market cap has increased by 12.78% in one year.
Market Cap
8.95B
Enterprise Value
9.03B
Revenue
1.68B
Ranking
n/a
PE Ratio
23.04
Stock Price
22.19
Market Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 8.95B, an increase of 85.25%. That is a compound annual growth rate of 11.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 9.13B | -10.32% |
| Dec 31, 2025 | 10.18B | 18.61% |
| Dec 31, 2024 | 8.58B | -18.20% |
| Dec 29, 2023 | 10.49B | 4.58% |
| Dec 30, 2022 | 10.03B | 13.58% |
| Dec 31, 2021 | 8.83B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liaoning Chengda Biotechnology | 10.17B |
| Beijing Hotgen Biotech | 10.11B |
| Youcare Pharmaceutical Group | 9.73B |
| Jiangxi Fushine Pharmaceutical | 9.72B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.00B |
| Sino Biological,Inc. | 8.98B |
| GemPharmatech | 8.94B |
| Zhejiang Ausun Pharmaceutical | 8.55B |